Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
03/2013
03/06/2013CN101959862B Improved process for the manufacture of 2, 3-dichloropyridine
03/06/2013CN101875629B Industrial preparation method of pantoprazole intermediate pyridine hydrochloride
03/06/2013CN101728485B Radialene compounds and their use
03/06/2013CN101142175B Peptidic compounds
03/05/2013US8389767 Processes and compounds
03/05/2013US8389734 Amides useful as inhibitors of voltage-gated sodium channels
03/05/2013US8389730 Compositions and methods for the treatment of disease associated with TRP-P8 expression
03/05/2013US8389570 Hydroxamates as therapeutic agents
03/05/2013US8389553 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
03/05/2013US8389551 Optical enantiomers of phenyramidol and process for chiral synthesis
03/05/2013US8389525 Small molecules for inhibition of protein kinases
03/05/2013US8389500 Fused heterocyclic compounds as ion channel modulators
03/05/2013US8389442 N-phenyl-′(4-pyridyl)-azinyl!amine derivatives as plant protection agents
03/05/2013CA2708324C Viral polymerase inhibitors
03/05/2013CA2569883C Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
02/2013
02/28/2013WO2013028543A1 Bax agonist, compositions, and methods related thereto
02/28/2013WO2013027660A1 Pesticide
02/28/2013WO2013026790A1 Luminescent lanthanide chelates having three chromophores and their use
02/28/2013US20130053574 Asymmetric hydrogenation method for ketone compound
02/28/2013US20130053573 2,4,5-triaminophenols and related compounds
02/28/2013US20130053420 Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients With Demyelinating and Other Nervous System Conditions
02/28/2013US20130053417 Cetp activity inhibitors
02/28/2013US20130053392 Carbonic anhydrase inhibitors
02/28/2013US20130053364 Sulphone Compounds and Methods of Making and Using Same
02/28/2013US20130052137 Para amino benzoic acid based nanotubes
02/28/2013US20130048007 Novel cationic 4- aminoindoles, dye composition comprising a cationic 4-aminoindole, processes therefor and uses thereof
02/28/2013CA2848726A1 Bax agonist, compositions, and methods related thereto
02/27/2013EP2562159A1 Preparation method of fluoro-substituted deuterated diphenylurea
02/27/2013EP2562158A1 Processes for the preparation of n-heteroaryl-N-aryl-amines by reacting an N-aryl carbamic acid ester with a halo-heteroaryl and analogous processes
02/27/2013EP2562157A1 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof
02/27/2013EP2560956A1 Novel synthesis for thiazolidinedione compounds
02/27/2013EP2560634A1 Nitric oxide releasing prodrugs of therapeutic agents
02/27/2013CN102947415A Organic electronic devices comprising a layer of a pyridine compound and a 8-hydroxyquinolinolato earth alkaline metal, or alkali metal complex
02/27/2013CN102947272A 2 -aminopyridine derivatives useful as inhibitors of atr kinase
02/27/2013CN102947271A Process for the preparation of 4- {4-[({[4 -chloro-3 -(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3-fluorophenoxy}-n-methylpyridine-2-carboxamide, its salts and monohydrate
02/27/2013CN102947270A Process for preparing 4-hydroxypyridines
02/27/2013CN102947269A Novel synthesis for thiazolidinedione compounds
02/27/2013CN102942589A Salts of isophosphoramide mustard and analogs thereof
02/27/2013CN102942523A Preparation method of omeprazole intermediate 2,3,5-trimethylpyridyl-N-oxide
02/27/2013CN102942522A Heterocyclic inhibitors of mek and methods of use thereof
02/27/2013CN102942521A Preparation method of roflumilast
02/27/2013CN102942520A p38 MAP激酶抑制剂 p38 MAP kinase inhibitors
02/27/2013CN102942519A Nitenpyram hapten, artificial antigen and antibody, their preparation methods and application thereof
02/27/2013CN102942518A Chlorination synthesis method of pyridine derivatives
02/27/2013CN102942517A Conjugated expanded viologen derivative as well as preparation method and application thereof
02/27/2013CN102942429A Method for preparing aza or thia aryl biaryl compound by aid of palladium and carbon catalysts
02/27/2013CN101875628B Preparation method of paraquat chloride
02/27/2013CN101346336B 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof
02/26/2013US8383827 Aryl pyridine as aldosterone synthase inhibitors
02/26/2013US8383826 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
02/26/2013US8383824 Heterocyclic antiviral compounds
02/26/2013US8383653 SIR2 regulation
02/26/2013US8383652 Biaromatic compounds that modulate PPAR-receptors
02/26/2013US8383641 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
02/26/2013US8383628 Pyridyl derivatives and their use as therapeutic agents
02/26/2013CA2532176C New 2-pyridinylethylbenzamide compounds
02/21/2013WO2013024888A1 Separation material, and separation method using said separating material
02/21/2013WO2013024384A1 Improved process for preparation of dabigatran etexilate and its novel intermediate
02/21/2013WO2013024169A1 Carbamoylmethoxy- and carbamoylmethylthio- and carbamoylmethylamino benzamides for combating invertebrate pests
02/21/2013WO2013024119A1 Ruthenium-based complex catalysts
02/21/2013WO2013024005A1 Anthranilamide compounds and their use as pesticides
02/21/2013WO2013024003A1 N-thio-anthranilamide compounds and their use as pesticides
02/21/2013WO2012010538A3 Novel processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide
02/21/2013US20130046098 Kinase inhibitors
02/21/2013US20130045972 Glucocorticoid receptor antagonists
02/21/2013US20130045869 Complexes of herbicidal carboxylic acids and amine-containing polymers or oligomers
02/21/2013DE102012016192A1 New compounds capable of forming hydrogen bonds are useful in electronic device, e.g. organic electroluminescent device, organic light-emitting transistor and organic light-emitting electrochemical cell
02/21/2013CA2843083A1 Anthranilamide compounds and their use as pesticides
02/20/2013EP2559455A1 Heteroaryl derivatives as DGAT1 inhibitors
02/20/2013EP2558448A1 Process for the preparation of 4- {4-[({[4 -chloro-3 -(trifluoromethyl)-phenyl]amino}carbonyl)amino]-3-fluorophenoxy}-n-methylpyridine-2-carboxamide, its salts and monohydrate
02/20/2013EP2558094A1 Pyridone derivatives
02/20/2013CN202741133U Reaction crystallization kettle used for granulation preparation method for ionic liquid of solid state in low temperature
02/20/2013CN202741101U Nicotinamide reaction still
02/20/2013CN102939279A Phenylthioacetate compounds, compositions and methods of use
02/20/2013CN102936220A BOC protection method for aminopyridine
02/20/2013CN102935378A Anti-coking catalyst and preparation method and applications thereof
02/20/2013CN101959427B Flavor molecules
02/19/2013US8378114 N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same
02/19/2013US8378113 Process for the manufacture of an intermediate in the synthesis of dabigatran
02/19/2013US8378112 Glycyrrhetinic acid derivative and use thereof
02/19/2013US8378107 Heteroaryl antagonists of prostaglandin D2 receptors
02/19/2013US8378099 Boronic ester and acid compounds, synthesis and uses
02/19/2013US8377971 Non-flushing niacin analogues, and methods of use thereof
02/19/2013US8377926 Aminopyridine kinase inhibitors
02/19/2013US8377422 Carboxamide derivatives having cooling properties
02/19/2013CA2568808C Chemical compounds
02/19/2013CA2456551C Tumour inhibiting lanthanum compounds
02/14/2013WO2013023109A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (coupled tricyclic core compounds)
02/14/2013WO2013023108A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (heteroarylene spacer moiety)
02/14/2013WO2013023107A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (electron withdrawing groups)
02/14/2013WO2013023106A1 Coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling (acyl moieties)
02/14/2013WO2013022047A1 Cyclopropaneamine compound
02/14/2013WO2013021276A1 Trpv1 antagonists including dihydroxy substituent and uses thereof
02/14/2013WO2013021021A1 Novel soft pde4 inhibitors
02/14/2013WO2013020938A1 Method for the preparation of chlorinated pyridines
02/14/2013WO2013020460A1 Atazanavir preparation method
02/14/2013WO2012012278A3 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex
02/14/2013US20130041156 Azapeptide derivatives
02/14/2013US20130041155 Carbon nanoring, method for producing same, compound suitable as starting material for producing the carbon nanoring, and method for producing the compound
02/14/2013US20130040998 Fluorinated hdac inhibitors and uses thereof
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 633